Czech Medical Herbs (CMH) is a gateway to wholesale pharmaceutical distribution, clinical trials and botanical research in the world of Medical Grade Cannabis. CMH is a wholesales pharmaceutical distributor with an added value. The added value is represented by provided professional services and focus on Cannabinoids. Beside Wholesale Pharmaceutical Distribution, CMH has a proven track record in organizing Clinical Trials in Czech Clinics and Botanical Research in Czech Science Institution.
Ensure that eligible groups of patients access treatment by legal means and to have high-quality cannabis for medicinal purposes. Exploit the full therapeutic potential of therapeutic cannabis with regard to individual patient needs and with respect to the applicable laws and regulations. Become the Czech leader in cannabinoids products import and one of the Czech licensed Cannabis growers. The vision is to build a stable company with sustainable development. To secure a reasonable profit for every shareholder.
Building on ongoing scientific research and in conjunction with clinical practice, we started the distribution of imported cannabis for therapeutic use in the Czech Republic in 2013. We believe that international cooperation will help us to build a stable position as a dominant supplier of Medical Grade Cannabis and other sophisticated products within cannabinoids treatment. Czech Medical Herbs is ready to apply for a Cannabis Growing license and to meet qualification factors as the company successfully did in 2014.
History of the Company
Czech Medical Herbs, s.r.o. (CMH) was established in May 2013. The company had a clear vision – to get the very first Czech license for Medical Cannabis growing and become the largest Czech producer and importer of Medical Cannabis. In the same year, the company applied and successfully met conditions to obtain a license for a wholesales pharmaceutical distribution awarded by the State Institute of Drug Control (SÚKL). This license was a precondition for application for the second license in order to become an importer of Medical Cannabis – License for handling with psychotropic drugs awarded by the Czech Ministry of Health. The company also met all qualifications and became the very first Czech importer of Medical Cannabis to Czech pharmacies in 2014. In mid-2014 CMH took part in a public tender in order to get the first growing license. There were 16 companies and 3 of these met qualifications requirements. CMH was one of the successful companies. The second round expected an offer of a hidden price and the lowest price was expected to win. CMH did not have the lowest offer and did not receive the first and the only one growing license. The strategic partner for CMH was an Israeli licensed cannabis producer.
CMH has imported or imports, the following Medical Cannabis into the Czech Republic: Bedrocan (Netherland), Tilray (Canada) and Aurora (Canada).
CMH outsourced management activity within a project of Cannabis cultivation in the Czech Republic in 2017 and 2018. An Australian company MGC Pharmaceutical through a local company PANAX Pharma financed the project. The Czech Republic can expect a sales boom of Medical Cannabis in 2020 thanks to an expected 90% reimbursement of Medical Cannabis from public health insurance. The Chamber of Deputies, Parliament of the Czech Republic approved an amendatory act in June 2019. The reimbursement is due to commence in January 2020.